Skip to main content

Table 1 Patient demographics and AGR2 expression by subgroups

From: High expression of AGR2 in lung cancer is predictive of poor survival

AGR2 expression (integrated mean intensity) by subgroups

Group

n

(mean ± SEM)

P-value

Gender

  

0.025b

 Women

205

1.33 ± 0.04

 

 Men

194

1.18 ± 0.04

 

Stage

  

0.202a

 Stage I

224

1.29 ± 0.04

 

 Stage II

70

1.16 ± 0.07

 

 Stage III

77

1.30 ± 0.07

 

 Stage IV

27

1.09 ± 0.09

 

Grade

  

0.004a

 Grade 1

63

1.34 ± 0.08

 

 Grade 2

112

1.33 ± 0.06

 

 Grade 3

158

1.26 ± 0.05

 

 Grade 4

35

0.94 ± 0.07

 

Histology

  

1.07e-11a

Adenocarcinoma

233

1.43 ± 0.04

 

Adenosquamous carcinoma

19

1.36 ± 0.14

 

Squamous cell carcinoma

104

1.00 ± 0.05

 

Undifferentiated carcinoma

33

0.96 ± 0.07

 

Smoking status

  

3.50e-04a

Non-smokers

52

1.55 ± 0.09

 

Former smokers

158

1.27 ± 0.04

 

Current smokers

128

1.12 ± 0.05

 
  1. aKruskal-Wallis test
  2. bMann-Whitney U test